Literature DB >> 10777840

It's what the surgeon doesn't see that kills the patient.

P H Sugarbaker1.   

Abstract

Peritoneal dissemination can be prevented by the responsible surgeon at least in part by proper surgical technique used to resect the primary malignancy. What most people do not know is that cancer surgery can do great harm. It can convert a contained malignant condition into a disseminated disease that unnecessarily becomes a deadly process. Containment must be the number one priority of the gastrointestinal cancer surgery. Also, established peritoneal carcinomatosis can be cured if it is attacked in a timely fashion with peritonectomy procedures and heated intraoperative intraperitoneal chemotherapy. Many small changes can make a big difference in survival with gastrointestinal cancer surgery.

Entities:  

Mesh:

Year:  2000        PMID: 10777840     DOI: 10.1272/jnms.67.5

Source DB:  PubMed          Journal:  J Nippon Med Sch        ISSN: 1345-4676            Impact factor:   0.920


  15 in total

1.  Hemicolectomy with concomitant heated intraperitoneal chemotherapy: a case study.

Authors:  Jeffery P Edwards; Britt Rodenberg; Scott D Niles; James Ploessl
Journal:  J Extra Corpor Technol       Date:  2005-03

2.  Long-term results after proactive management for locoregional control in patients with colonic cancer at high risk of peritoneal metastases.

Authors:  P Sammartino; S Sibio; D Biacchi; M Cardi; P Mingazzini; M S Rosati; T Cornali; B Sollazzo; J Maherfouad Atta; A Di Giorgio
Journal:  Int J Colorectal Dis       Date:  2014-07-01       Impact factor: 2.571

Review 3.  Review of management and treatment of peritoneal metastases from gastric cancer origin.

Authors:  Israel Manzanedo; Fernando Pereira; Ángel Serrano; Estíbalitz Pérez-Viejo
Journal:  J Gastrointest Oncol       Date:  2021-04

4.  Peritoneal Surface Disease Severity Score (PSDSS), AGO-score and TIAN model in patients with platinum-sensitive recurrent ovarian cancer treated by cytoreductive surgery plus HIPEC.

Authors:  Álvaro Jesús Gómez-Ruiz; Alida González-Gil; José Gil; Álvaro Navarro-Barrios; Felipe Alconchel; Elena Gil; Jerónimo Martínez; Aníbal Nieto; Francisco Barceló; Pedro Antonio Cascales-Campos
Journal:  Clin Exp Metastasis       Date:  2019-07-03       Impact factor: 5.150

5.  The use of cisplatin plus doxorubicin or paclitaxel in hyperthermic intraperitoneal chemotherapy (HIPEC) for stage IIIC or IV epithelial ovarian cancer: a comparative study.

Authors:  I Manzanedo; F Pereira; Á Serrano; E Pérez-Viejo; B Martínez-Torres; L Carrión; J Calzas
Journal:  Clin Transl Oncol       Date:  2019-02-20       Impact factor: 3.405

Review 6.  Proactive Management for Gastric, Colorectal and Appendiceal Malignancies: Preventing Peritoneal Metastases with Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

Authors:  Paolo Sammartino; Daniele Biacchi; Tommaso Cornali; Maurizio Cardi; Fabio Accarpio; Alessio Impagnatiello; Bianca Maria Sollazzo; Angelo Di Giorgio
Journal:  Indian J Surg Oncol       Date:  2016-01-26

Review 7.  Multimodality treatment strategies have changed prognosis of peritoneal metastases.

Authors:  Corneliu Lungoci; Aurel Ion Mironiuc; Valentin Muntean; Traian Oniu; Hubert Leebmann; Max Mayr; Pompiliu Piso
Journal:  World J Gastrointest Oncol       Date:  2016-01-15

Review 8.  Treatment of peritoneal carcinomatosis from ovarian cancer. Present, future directions and proposals.

Authors:  F C Muñoz-Casares; S Rufián; M J Rubio; E Lizárraga; C Díaz-Iglesias; E Aranda; R Ciria; J Muntané; P Barrios; J Torres-Melero; S González-Moreno; L González-Bayón; B Camps; P Bretcha; J Farré; G Ortega-Pérez; A Gómez-Portilla
Journal:  Clin Transl Oncol       Date:  2007-10       Impact factor: 3.405

9.  The role of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in the treatment of peritoneal carcinomatosis in recurrent ovarian cancer.

Authors:  Francisco C Muñoz-Casares; Sebastián Rufián; María J Rubio; Carlos J Díaz; Rafael Díaz; Angela Casado; Alvaro Arjona; María C Muñoz-Villanueva; Jordi Muntané
Journal:  Clin Transl Oncol       Date:  2009-11       Impact factor: 3.405

10.  Peritoneal dissemination of hepatoid carcinoma of the ovary treated with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy.

Authors:  Pedro Antonio Cascales Campos; Jose Gil Martinez; Amparo Torroba; Francisco Machado; Pascual Parrila Paricio
Journal:  Case Rep Med       Date:  2013-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.